After a sharp drop in out-of-pocket costs between 2010 and 2011, Medicare patients who use specialty biologic medications for rheumatoid arthritis have seen higher out-of-pocket spending for those same drugs because of gradual ...
May 1, 2020
0
4
An arthritis drug that was being closely watched for its potential use against COVID-19 has delivered disappointing results in clinical trials, its makers said Monday.
Apr 28, 2020
0
109
Although today's rheumatoid arthritis treatments can reduce symptoms, they often come with serious side effects. Results from a new mouse study suggest that a new light-activated drug delivery method helps confine treatments ...
Apr 27, 2020
0
2
French pharmaceutical giant Sanofi said Friday it would offer 100 million doses of hydroxychloroquine, a treatment for rheumatoid arthritis and lupus, to governments worldwide if studies show it can safely to be used to ...
Apr 10, 2020
0
3
Chloroquine, hydroxychloroquine and azithromycin are being used to treat and prevent COVID-19 despite weak evidence for effectiveness, and physicians and patients should be aware of the drugs' potentially serious adverse ...
Apr 8, 2020
0
112
Methotrexate is a common drug with a long history; for the past 40 years, it's been used to treat a range of diseases. Today it is the most commonly used drug for systemic rheumatic diseases worldwide and is the first drug ...
Feb 17, 2020
0
40
New research has shown the potential for clinically available cancer treatments to treat chronic obstructive pulmonary disease (COPD).
Jan 6, 2020
0
298
Attaching a removable lock to an arthritis drug can make it safer and more effective, according to a new study publishing June 13 in the open-access journal PLOS Biology led by Wen-Wei Lin of Kaohsiung Medical University, ...
Jun 13, 2019
0
5
A new computational framework has revealed key differences between four rheumatoid arthritis medications and their impact on biological pathways in mice. Niki Karagianni of Biomedcode Hellas SA, Greece, and colleagues present ...
May 9, 2019
0
4
(HealthDay)—An algorithm that can classify patients with juvenile idiopathic arthritis (JIA) into seven distinct groups based on patterns of swollen or painful joints in the body can help predict disease course, according ...
Mar 11, 2019
0
1
